Sign Up to like & get
recommendations!
1
Published in 2020 at "Clinical Pharmacology in Drug Development"
DOI: 10.1002/cpdd.841
Abstract: Fixed‐dose combination (FDC) drugs with various dose combinations for the treatment of type 2 diabetes mellitus and dyslipidemia are currently in demand. We compared the pharmacokinetic (PK) profiles of the rosuvastatin/metformin sustained‐release (10/1000 mg) FDC…
read more here.
Keywords:
rosuvastatin metformin;
metformin;
sustained release;
metformin sustained ... See more keywords